Carl D. Regillo, MD, FACS, FASRS, discusses geographic atrophy, the advanced stage of dry age-related macular degeneration, including its diagnosis, and progression.
The FDA accepts revised supplemental New Drug Application for IZERVAY
Spotlighting telemedicine in the year of a pandemic
Ocugen will continue second phase of OCU410 ArMaDa clinical trial
Galimedix Therapeutics initiates eDREAM phase 2 clinical trial in dry age-related macular degeneration
Ophthalmic safety notice: Potential fungal contamination prompts Systane Ultra PF voluntary recall
The human impact of geographic atrophy: Survey examines experiences and perceptions of patients living with GA